N
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
Price:
36.8
TWD
1.1%
Market Closed
Market Cap:
NT$3.7B
Relative Value
The Relative Value of one Nang Kuang Pharmaceutical Co Ltd stock under the Base Case scenario is hidden TWD. Compared to the current market price of 36.8 TWD, Nang Kuang Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Nang Kuang Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Nang Kuang Pharmaceutical Co Ltd Competitors
Nang Kuang Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TW |
N
|
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
|
3.7B TWD | 1.7 | 14.5 | 8.5 | 13.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
946.1B USD | 14.5 | 45.8 | 30.9 | 33 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.8B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
263.4B CHF | 4.3 | 20.3 | 12 | 13.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.3B GBP | 5.1 | 29.4 | 16.3 | 23 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.9B CHF | 5.3 | 21.4 | 13.2 | 17 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
289.8B USD | 4.5 | 15.9 | 9.9 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121B USD | 2.5 | 17.2 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
